Insulet (PODD) Misses Q2 EPS
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $147.48 -2.06%
EPS Growth %: +28.2%
Financial Fact:
Cost of revenue: 39.23M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +28.2%
Financial Fact:
Cost of revenue: 39.23M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q2 EPS of ($0.37), which may not compare to the analyst estimate of $0.13. Revenue for the quarter came in at $263.2 million versus the consensus estimate of $259.19 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- JPMorgan Downgrades Woolworths Holdings Ltd (WHL:SJ) to Underweight
- Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
